Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...
The prevalence of inappropriate direct oral anticoagulant (DOAC) dosing in patients with atrial fibrillation (AF) was 25%. Several demographic factors such as advanced age, presence of chronic kidney ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
The risk for death goes up for patients with atrial fibrillation (AF) who are put on direct oral anticoagulants (DOAC) at dosages other than those approved for stroke prevention, whether higher or ...
A first-of-its-kind exploratory study finds that over half of frail, older patients admitted to the hospital for acute illness and are on blood thinners from the direct oral anticoagulant (DOAC) class ...
The use of a population health management tool may reduce adverse events that may arise from the inappropriate prescribing of direct-acting oral anticoagulants (DOACs). The inappropriate use of direct ...
WEDNESDAY, Sept. 25, 2024 (HealthDay News) -- Early adoption of the direct oral anticoagulant (DOAC) population management dashboard, the purpose of which includes pharmacist review and correction of ...
Oversight identifies errors, especially in a-fib patients, who mainly have alerts for off-label prescribing during follow-up period. HealthDay News — Direct oral anticoagulant (DOAC) prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback